Response to: Evaluation of the serum matrix metalloproteinase-9 as a biomarker for monitoring disease progression in Duchenne muscular dystrophy

Affiliations

¹ Department of Human Genetics, Leiden University Medical Center, Postzone S4-P, P.O. Box 9600, Leiden 2300 RC, Netherlands.
² Department of Human Genetics, Leiden University Medical Center, Postzone S4-P, P.O. Box 9600, Leiden 2300 RC, Netherlands. Electronic address: p.a.c.hoen@lumc.nl.

Comment

Pietro Spitali et al. Neuromuscul Disord. 2015 May.

. 2015 May;25(5):446-7.

doi: 10.1016/j.nmd.2015.02.011. Epub 2015 Feb 23.

¹ Department of Human Genetics, Leiden University Medical Center, Postzone S4-P, P.O. Box 9600, Leiden 2300 RC, Netherlands.
² Department of Human Genetics, Leiden University Medical Center, Postzone S4-P, P.O. Box 9600, Leiden 2300 RC, Netherlands. Electronic address: p.a.c.hoen@lumc.nl.

No abstract available

Comment on

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD).
Nadarajah VD, van Putten M, Chaouch A, Garrood P, Straub V, Lochmüller H, Ginjaar HB, Aartsma-Rus AM, van Ommen GJ, den Dunnen JT, 't Hoen PA. Nadarajah VD, et al. Neuromuscul Disord. 2011 Aug;21(8):569-78. doi: 10.1016/j.nmd.2011.05.011. Epub 2011 Jul 2. Neuromuscul Disord. 2011. PMID: 21724396
Evaluation of the serum matrix metalloproteinase-9 as a biomarker for monitoring disease progression in Duchenne muscular dystrophy.
Zocevic A, Rouillon J, Wong B, Servais L, Voit T, Svinartchouk F. Zocevic A, et al. Neuromuscul Disord. 2015 May;25(5):444-6. doi: 10.1016/j.nmd.2015.01.010. Epub 2015 Feb 2. Neuromuscul Disord. 2015. PMID: 25791581 No abstract available.